Page 93 - Technology Platform News Today

Unveiling the Strengths and Challenges: A Deep Dive into Toast Inc's SWOT Analysis

REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $20.02, but opened at $19.01. REGENXBIO shares last traded at $19.31, with a volume of 61,047 shares trading hands. The biotechnology company reported ($1.43) EPS for […]

REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $20.02, but opened at $19.01. REGENXBIO shares last traded at $19.31, with a volume of 61,047 shares trading hands. The biotechnology company reported ($1.43) EPS for […]

REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report)’s share price gapped down prior to trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $20.02, but opened at $19.01. REGENXBIO shares last traded at $19.31, with a volume of 61,047 shares trading hands. The biotechnology company reported ($1.43) […]

REGENXBIO (NASDAQ:RGNX – Get Free Report) posted its quarterly earnings results on Tuesday. The biotechnology company reported ($1.43) earnings per share for the quarter, missing the consensus estimate of ($1.27) by ($0.16), Briefing.com reports. The firm had revenue of $22.30 million for the quarter, compared to the consensus estimate of $34.01 million. REGENXBIO had a […]

REGENXBIO (NASDAQ:RGNX – Get Free Report) issued its quarterly earnings results on Tuesday. The biotechnology company reported ($1.43) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.27) by ($0.16), Briefing.com reports. The company had revenue of $22.30 million during the quarter, compared to analysts’ expectations of $34.01 million. REGENXBIO had a negative […]

REGENXBIO (NASDAQ:RGNX – Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.27) by ($0.16), Briefing.com reports. The firm had revenue of $22.30 million for the quarter, compared to analyst estimates of $34.01 million. REGENXBIO had a […]

Strategic Focus and Pipeline Advancements Amid Financial Prudence

According to HR solution firm Aon’s Annual Salary Increase and Turnover Survey 2023-2024 for India, here's the salary hike calculation for the new year.

Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price target […]